CANDOO and CANOAR, CORRONA and More: Advancing Therapeutics Through Layered-in Clinical Data Collection and Feedback at the Point of Care

Journal of Rheumatology

Volumn 30, Issue 11, 2003, Pages 2308-2311

  Sebaldt, Rolf J ^a,c   Kremer, Joel M ^b  

^a ST JOSEPH S HOSPITAL   (Canada)

^b Center for Rheumatology LLP   (United States)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID;

ACNE; BONE DENSITY; CLINICAL PRACTICE; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; COST EFFECTIVENESS ANALYSIS; EPIDEMIOLOGICAL DATA; FEEDBACK SYSTEM; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; MEDICAL SOCIETY; OSTEOARTHRITIS; OSTEOPENIA; OSTEOPOROSIS; PATIENT CARE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; RHEUMATOID ARTHRITIS;

CANADA; DATA COLLECTION; DATABASES, FACTUAL; FEEDBACK; HUMANS; NORTH AMERICA; POINT-OF-CARE SYSTEMS;

EID: 0242524401     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Felson DT. Clinical trials in rheumatoid arthritis under attack: Are practice based observational studies the answer? [editorial]. J Rheumatol 1991;18:951-3.
2. Hawley DJ, Wolfe F. Are the results of controlled clinical trials and observational studies of second line therapy in rheumatoid arthritis valid and generalizable as measures of rheumatoid arthritis outcome: analysis of 122 studies. J Rheumatol 1991;18:1008-14.
3. Kvien TK, Mikkelsen K, Nordvag B-Y. Results from controlled clinical trials: how relevant for clinical practice? [editorial]. J Rheumatol 2003;30:1135-7.
4. Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent trials or American College of Rheumatology criteria for remission. J Rheumatol 2003;30:1138-46.
5. Pincus T. Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases. Semin Arthritis Rheum 1993;23 Suppl 1:2-10.
6. Maetzel A, Bombardier C. Give observational studies a chance: better observational studies make better economic evaluations [editorial]. J Rheumatol 1999;26:2298-9.
7. Fries JF, McShane DJ. ARAMIS (the American Rheumatism Association Medical Information System). A prototypical national chronic-disease data bank. West J Med 1986;145:798-804.
8. Pincus T, Brooks RH, Callahan LF. A proposed 30-45 minute 4 page standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes. J Rheumatol 1999;26:473-80.
9. Wolfe F. A database for rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:481-500.
10. Olszynski W, Ioannidis G, Sebaldt RJ, et al. The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database For Osteoporosis and Osteopenia (CANDOO). BMC Musculoskelet Disord 2002;3:22.
11. Sebaldt RJ, Petrie A, Goldsmith CH, Marentette M. Characteristics of patients with OA receiving NSAID prescriptions from their primary care physicians. Results of the CANOAR study [abstract]. Arthritis Rheum 2001;44Suppl:S144.